Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
ClinicalTrials.gov study NCT03217422. IPD Sharing: YES. Countries: 10. Publications: 2.
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04088890. IPD Sharing: NO. Countries: 1. Publications: 2.
Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03023878. IPD Sharing: YES. Countries: 6. Publications: 1.
Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01325701. IPD Sharing: NO. Countries: 1. Publications: 1.
CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT03289455. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
ClinicalTrials.gov study NCT03932331. IPD Sharing: YES. Countries: 1. Publications: 1.
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT00783367. IPD Sharing: Not stated. Countries: 1. Publications: 24.
Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00445341. IPD Sharing: NO. Countries: 1. Publications: 3.
Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02446457. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
ClinicalTrials.gov study NCT00801216. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
ClinicalTrials.gov study NCT03888105. IPD Sharing: YES. Countries: 14. Publications: 3.
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01318317. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT00799513. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell
ClinicalTrials.gov study NCT01088048. IPD Sharing: YES. Countries: 1. Publications: 3.
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)
ClinicalTrials.gov study NCT02998476. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04665765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02253992. IPD Sharing: Not stated. Countries: 4. Publications: 1.
CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00290472. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation
Open the record for dataset details and reuse information.
Antigen-Independent, Autonomous B-cell Receptor Signalling in Diffuse Large B-cell Lymphoma
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.